nach oben

Graefe's Archive for Clinical and Experimental Ophthalmology

Erschienen in:

03.04.2023 | Oncology

Comparing internal versus external carotid artery branch delivery of intraarterial chemotherapy for the treatment of retinoblastoma

verfasst von: Emily Chang, Yunshu Zhou, David Musch, Amy Edmonds, Laura Sedig, Raymond Hutchinson, Neeraj Chaudhary, Hakan Demirci

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The goal of this study was to compare the efficacy of intraarterial chemotherapy (IAC) for retinoblastoma delivered via the ophthalmic artery (OA) division of the internal carotid artery (ICA) versus alternative branches of the external carotid artery (ECA).

Methods

We performed a retrospective chart review of patients receiving IAC for retinoblastoma at a single institution. Subjects were divided into three groups: those that received IAC solely through the OA branch of the ICA, those that initially received IAC through the OA branch of the ICA but were later switched to the ECA, and those that only received IAC through the ECA. The main outcomes compared included globe salvage rate and reduction in tumor thickness and size.

Results

A total of 30 eyes from 26 patients were included. A total of 91 (58%) sessions of IAC were performed through the OA division of the ICA and 65 (42%) were performed through branches of the ECA. Eleven eyes (37%) solely received IAC through the OA branch of the ICA, 16 eyes (53%) were converted to ECA treatment, and 3 eyes solely received IAC through branches of the ECA. Statistical analysis did not show any significant difference in globe salvage rate or reduction in tumor thickness and size.

Conclusion

The use of alternative approaches for IAC when the OA branch of the ICA catheterization is not feasible allows for safe continued delivery of highly effective IAC, leading to similar outcomes in terms of globe salvage and reduction in tumor size.

Nur mit Berechtigung zugänglich

Gobin YP, Dunkel IJ, Marr BP et al (2011) Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol Chic Ill 1960 129:732–737. https://doi.org/10.1001/archophthalmol.2011.5CrossRef

Manjandavida F, Stathopoulos C, Zhang J et al (2019) Intra-arterial chemotherapy in retinoblastoma – a paradigm change. Indian J Ophthalmol 67:740–754. http://dx.doi.org.proxy.lib.umich.edu/10.4103/ijo.IJO_866_19

Yamane T, Kaneko A, Mohri M (2004) The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol 9:69–73. https://doi.org/10.1007/s10147-004-0392-6CrossRefPubMed

Shields CL, Shields JA (2010) Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey. Clin Experiment Ophthalmol 38:638–643. https://doi.org/10.1111/j.1442-9071.2010.02297.xCrossRefPubMed

Bertelli E, Leonini S, Galimberti D et al (2016) Hemodynamic and anatomic variations require an adaptable approach during intra-arterial chemotherapy for intraocular retinoblastoma: alternative routes, strategies, and follow-up. Am J Neuroradiol 37:1289–1295. https://doi.org/10.3174/ajnr.A4741CrossRefPubMedPubMedCentral

Quinn C, Tummala R, Anderson J et al (2019) Effectiveness of alternative routes of intra-arterial chemotherapy administration for retinoblastoma: potential for response and complications. Interv Neuroradiol J Peritherapeutic Neuroradiol Surg Proced Relat Neurosci 25:556–561. https://doi.org/10.1177/1591019919831953CrossRef

Sweid A, Hammoud B, Texakalidis P et al (2020) The use of alternative routes for the delivery of intra-arterial chemotherapy for retinoblastoma. Neurosurgery 87:956–963. https://doi.org/10.1093/neuros/nyaa142CrossRefPubMed

Shields CL, Mashayekhi A, Au AK et al (2006) The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 113:2276–2280. https://doi.org/10.1016/j.ophtha.2006.06.018CrossRefPubMed

Abramson DH, Fabius AWM, Issa R et al (2015) Advanced unilateral retinoblastoma: the impact of ophthalmic artery chemosurgery on enucleation rate and patient survival at MSKCC. PloS One 10:e0145436. https://doi.org/10.1371/journal.pone.0145436CrossRefPubMedPubMedCentral

10.

Munier FL, Mosimann P, Puccinelli F et al (2017) First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment. Br J Ophthalmol 101:1086–1093. https://doi.org/10.1136/bjophthalmol-2016-309298CrossRefPubMed

11.

Abramson DH, Marr BP, Dunkel IJ et al (2012) Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results. Br J Ophthalmol 96:499–502. https://doi.org/10.1136/bjophthalmol-2011-300498CrossRefPubMed

12.

Chen M, Jiang H, Zhang J et al (2017) Outcome of intra-arterial chemotherapy for retinoblastoma and its influencing factors: a retrospective study. Acta Ophthalmol (Copenh) 95:613–618. https://doi.org/10.1111/aos.13333CrossRef

13.

Chen Q, Zhang B, Dong Y et al (2019) Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age. BMC Cancer 19:693. https://doi.org/10.1186/s12885-019-5844-5CrossRefPubMedPubMedCentral

14.

Shields CL, Manjandavida FP, Lally SE et al (2014) Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the International Classification of Retinoblastoma. Ophthalmology 121:1453–1460. https://doi.org/10.1016/j.ophtha.2014.01.026CrossRefPubMed

15.

Jia S, Wen X, Zhou M et al (2021) Comparison of intra-arterial chemotherapy efficacy delivered through the ophthalmic artery or external carotid artery in a cohort of retinoblastoma patients. Front Med 8

16.

Kaliki S, Srinivasan V, Gupta A et al (2015) Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study. Ophthalmology 122:1165–1172. https://doi.org/10.1016/j.ophtha.2015.01.018CrossRefPubMed

17.

Biewald EM, Bornfeld N, Metz KA et al (2020) Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy. Br J Ophthalmol 104:1171–1175. https://doi.org/10.1136/bjophthalmol-2019-315209CrossRefPubMed

18.

Sweid A, El Naamani K, Sajja KC et al (2020) Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma. J Neurointerventional Surg. https://doi.org/10.1136/neurintsurg-2020-016759CrossRef

19.

Batu Oto B, Sarıcı AM, Kızılkılıç O (2020) Superselective intra-arterial chemotherapy treatment for retinoblastoma: clinical experience from a tertiary referral centre. Can J Ophthalmol J Can Ophtalmol 55:406–412. https://doi.org/10.1016/j.jcjo.2020.04.009CrossRef

20.

Rojanaporn D, Chanthanaphak E, Boonyaopas R et al (2019) Intra-arterial chemotherapy for retinoblastoma: 8-year experience from a tertiary referral institute in Thailand. Asia-Pac J Ophthalmol Phila Pa 8:211–217. https://doi.org/10.22608/APO.2018294CrossRef

21.

Pekacka A (2020) The role of intraarterial chemotherapy in the management of retinoblastoma. J Ophthalmol 2020:3638410. https://doi.org/10.1155/2020/3638410CrossRefPubMedPubMedCentral

22.

Shields CL, Mashayekhi A, Cater J et al (2004) Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol 138:329–337. https://doi.org/10.1016/j.ajo.2004.04.032CrossRefPubMed

23.

Wyse E, Handa JT, Friedman AD, Pearl MS (2016) A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma. Pediatr Radiol 46:1223–1233. https://doi.org/10.1007/s00247-016-3554-6CrossRefPubMed

Titel: Comparing internal versus external carotid artery branch delivery of intraarterial chemotherapy for the treatment of retinoblastoma
verfasst von: Emily Chang
Yunshu Zhou
David Musch
Amy Edmonds
Laura Sedig
Raymond Hutchinson
Neeraj Chaudhary
Hakan Demirci
Publikationsdatum: 03.04.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 9/2023
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-023-06037-w

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Comparing internal versus external carotid artery branch delivery of intraarterial chemotherapy for the treatment of retinoblastoma

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2023

Letter to the editor relating to Graefe’s Arch Clin Exp Ophthalmol. 2023 April; 261(4):951–957. “Blood neutrophil-to-lymphocyte ratio as a risk factor in the treatment of retinopathy of prematurity”

Comparison of the prediction accuracy of 13 formulas in long eyes

Drusen morphometrics on optical coherence tomography in eyes with age-related macular degeneration and normal aging

FOXM1 promotes TGF-β2-induced injury of human lens epithelial cells by up regulating VEGFA expression

Cytokine profiles in the aqueous humor following brolucizumab administration for exudative age-related macular degeneration

Correction to: Utility of isolated‑check visual evoked potential technique in dysthyroid optic neuropathy

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde